+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

World Enteric Disease Testing and Therapeutic Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773125
  • Report
  • September 2019
  • Region: Global
  • Allied Analytics LLP
1 of 2
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases. According to World Health Organization (WHO), around 2.2 million people are killed annually due to food and water-borne diarrheal diseases. There is an impending global demand for better diagnostic and therapeutic options to prevent the deaths from enteric diseases. The factors influencing the growth of enteric disease testing and therapeutic market are higher incidence of infectious diseases, overcrowded human population, poverty and lack of education about health and safety standards, unavailability of safe drinking water in many parts of the world and increasing microbial resistance to antibiotics. Moreover, according to WHO estimate, unfavorable changes in world climatic conditions such as rising global temperature and deforestation, would further increase the incidence of infectious diseases. However, inaccessibility to modern diagnostic and therapeutic options, high cost of equipment and lack of expertise are likely to restrict the growth of the market.

The global enteric disease testing and therapeutic market is segmented on the basis of disease, diagnostics, therapeutics and geography. According to disease, the market is segmented into bacterial disease such as typhoid, cholera, shigellosis, salmonellosis, clostridium difficile infections and campylobacteriosis; viral diseases such as rotavirus and novovirus infections; and parasitic diseases such as amoebiasis and giardiasis. Diagnostics market is segmented into diagnostic assays and rapid tests, testing of stool specimens, Complete Blood Count (CBC) test, blood culture test, urine test, antibody test and bone marrow test. Based on therapeutics, the global market is segmented into vaccines, antibiotics, Oral Rehydration Therapy (ORT) and others such as vitamins and zinc supplements. Geographically, the market is segmented across four regions viz., North America, Europe, Asia-Pacific and LAMEA.

Few of the strategies adopted by the key industry players are new product approval and acquisition. For instance, in May 2014, BD Diagnostics got FDA approval for BD MAX Enteric Bacterial Panel, an in vitro diagnostic test intended for the diagnosis of bacterial gastroenteritis. Similarly, Nanosphere Inc., got FDA approval for Verigene Enteric Pathogens Nucleic Acid Test (EP), a rapid diagnostic test for gastroenteritis. In July 2014, PaxVax acquired marketing, sales and distribution rights of Vivotif, an oral typhoid vaccine from Crucell Switzerland AG. The companies profiled in this report include Alere, Inc., GlaxoSmithKline plc, Becton Dickinson and Company, bioMérieux SA, Sanofi S.A., Bayer Pharma AG, Bio-Rad Laboratories, Inc., Quest Diagnostics Inc., and Trinity Biotech plc.

KEY MARKET BENEFITS:

Comprehensive analysis of factors that drive and restrict the growth of the global enteric disease testing and therapeutic market is provided in the report

The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities

An in-depth analysis of key segments of the market helps understand the types of enteric diseases along with the diagnostics and therapeutics currently being used in global enteric disease market

SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

Region-wise enteric disease testing and therapeutic market conditions are comprehensively analysed in the report

KEY MARKET SEGMENTS:

The global enteric disease testing and therapeutic market is segmented as below:

Global Enteric Disease Testing and Therapeutic Market - By Disease

Bacter



* This report will be delivered in 12 Business Days. *
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll